Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Moodys
Merck
Dow
McKesson

Last Updated: May 26, 2022

NASCOBAL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Nascobal patents expire, and what generic alternatives are available?

Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. There are six patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in NASCOBAL is cyanocobalamin. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

Paragraph IV (Patent) Challenges for NASCOBAL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NASCOBAL Nasal Spray cyanocobalamin 500 mcg/spray 021642 1 2017-04-28

US Patents and Regulatory Information for NASCOBAL

NASCOBAL is protected by six US patents.

Patents protecting NASCOBAL

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: NASAL ADMINISTRATION OF CYANOCOBALAMIN

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: CYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: NASAL ADMINISTRATION OF CYANOCOBALAMIN

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: CYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: SUPPLEMENT FOR VITAMIN B12 DEFICIENCIES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm NASCOBAL cyanocobalamin GEL, METERED;NASAL 019722-001 Nov 5, 1996 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NASCOBAL

See the table below for patents covering NASCOBAL around the world.

Country Patent Number Title Estimated Expiration
Japan S62500789 See Plans and Pricing
Canada 1300014 COMPOSITIONS NASAUX CONTENANT LA VITAMINE B (NASAL COMPOSITIONS CONTAINING VITAMIN B) See Plans and Pricing
Norway 865010 See Plans and Pricing
Japan H0669952 See Plans and Pricing
Ireland 860974 See Plans and Pricing
African Intellectual Property Organization (OAPI) 8486 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Medtronic
Boehringer Ingelheim
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.